Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:39 PM
Study NCT ID:
NCT04918667
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-09-14
First Post:
2021-06-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effect of Gamma-cyclodextrin on the Bioavailability of Berberine
Sponsor:
EuroPharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EP-1007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None